Description

Lercamen-20 Coated Tablets 20 mg. №60

Ingredients:

Each coated tablet contains 20 mg of Lercanidipine hydrochloride.

Mechanism of Action:

Lercanidipine hydrochloride, the active ingredient in Lercamen-20, is a calcium channel blocker that selectively inhibits the influx of calcium ions into vascular smooth muscle cells. By blocking calcium channels, it leads to vasodilation and reduces peripheral vascular resistance, thereby lowering blood pressure.

Pharmacological Properties:

Lercanidipine hydrochloride exhibits high selectivity for vascular smooth muscle cells, resulting in potent antihypertensive effects. It has a slow onset of action and provides sustained blood pressure control.

Indications for Use:

Lercamen-20 is indicated for the treatment of essential hypertension. It is effective in lowering high blood pressure, which helps in reducing the risk of cardiovascular events such as heart diseases and strokes.

Contraindications:

Avoid using Lercamen-20 if you have a known allergy to Lercanidipine or any other components of the tablets. It is contraindicated in patients with severe liver dysfunction due to the metabolism of the drug in the liver.

Side Effects:

Common side effects of Lercamen-20 may include dizziness, headache, flushing, peripheral edema, and palpitations. In rare cases, it may cause hepatotoxicity or allergic reactions. Consult your healthcare provider if you experience any adverse effects.

Usage Instructions:

The recommended dosage of Lercamen-20 is one tablet daily, preferably taken in the morning before breakfast. Swallow the tablet whole with a glass of water and do not crush or chew it. Consistent daily administration is essential for optimal blood pressure management.

Benefits Compared to Analogues:

Lercamen-20 offers the advantage of once-daily dosing, which enhances patient compliance. Its selective mechanism of action on vascular smooth muscle cells results in effective blood pressure control with a lower incidence of adverse effects compared to non-selective calcium channel blockers.

Suitable Patient Groups:

Lercamen-20 is suitable for adult patients with essential hypertension. It is generally well-tolerated in elderly individuals; however, dose adjustments may be necessary based on individual health conditions. The safety and efficacy of Lercanidipine in children have not been established.

Storage Conditions and Shelf Life:

Store Lercamen-20 in a cool, dry place away from direct sunlight. Keep the tablets in their original packaging to protect them from moisture. Check the expiration date on the package and do not use the product after the specified shelf life has passed.

Packaging Description:

Lercamen-20 is available in blister packs containing 60 coated tablets. Each tablet is imprinted with the product name and strength for easy identification.

Scientific Evidence:

Lercamen-20 has been extensively studied in clinical trials to establish its efficacy and safety in the management of hypertension. Research published in the Journal of Clinical Pharmacology demonstrated that Lercanidipine effectively reduces blood pressure levels without significant adverse effects.

Additional Information:

It is crucial to adhere to the prescribed dosage of Lercamen-20 as directed by your healthcare provider to achieve optimal blood pressure control. If you experience any unusual symptoms or side effects, promptly consult your doctor for further evaluation and management. Prior consultation with your healthcare provider is recommended before initiating Lercamen-20, especially if you have underlying medical conditions or are taking other medications to prevent potential drug interactions.